Trump’s tariff pause brings little relief as recession fears linger Donald Trump’s move to postpone most of his new tariffs for 90 days seems to have brought only fleeting relief for markets. After a huge rally on April 10, April 11 saw Asian stocks head lower again. KPERS saw a small gain in Q1 2025
Topline results for the Phase 2 Avail™ evaluating canvuparatide in patients with hypoparathyroidism expected in 3Q 2025 Investigational New Drug submission for MBX 4291 on track for 2Q 2025 $240.8 million in cash, cash equivalents and marketable securities as of March 31, 2025; expected to support operations into mid-2027 CARMEL, Ind., May 12, 2025 (GLOBE
On track to report topline results from Phase 2 BESTOW trial in kidney transplantation in fourth quarter of 2025 Tegoprubart used as a key component of immunosuppression regimen in its second transplant of a genetically modified pig kidney into a human conducted at Massachusetts General Hospital Cash, cash equivalents and short-term investments of $124.9 million
Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026 Cash, cash equivalents and marketable securities of $197.9 million as of March 31, 2025, expected to support current clinical and operational activities into early 2027 Company to host conference call
Early entry of RAS-targeting franchise into clinic enabled by strong execution Initial Phase 1 monotherapy data for pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 expected in 2026 Robust balance sheet with cash, cash equivalents, and marketable securities of $411 million as of March 31, 2025 with cash runway guidance extended to H2 2028 SAN DIEGO, May 13, 2025
DEI at the Gold Gala: Jon M. Chu celebrates Asian achievements While attending the Gold Gala, director Jon M. Chu reflected on the importance of Asian media representation in a conversation with USA TODAY. LOS ANGELES − In the midst of the White House’s unrelenting offensive against diversity initiatives, Hollywood gathered to celebrate the accomplishments
What’s really going on with gold prices? Gold recently reached a record high as geopolitical tensions pushed investors towards the traditional safe play. Merryn Somerset Webb explains what’s going on – and where things could go from here. Bloomberg – Politics Louisiana lawmakers are considering legislation to recognize gold and silver as legal tender. Eleven
Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors Interim analysis from Phase 2 PYNNACLE trial expected mid-2025; PMV plans to provide interim analysis data for approximately 50 patients with at least 18 weeks of follow-up Cash,
Pre-NDA Meeting for CTx-1301(dexmethylphenidate) Held April 2, 2025; New Drug Application Submission Targeted for Mid-2025 Non-Dilutive Funding to Accelerate Development of CTx-2103 (buspirone) KANSAS CITY, Kan., May 08, 2025 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a
– Sharpened product candidate focus on its next-generation ADC portfolio, following strategic review and pipeline reprioritization – – Promising preclinical results with STRO-004 and dual-payload ADC, as well as STRO-006 programs presented at AACR 2025 and PEGS, respectively – – Three INDs for wholly-owned programs anticipated in next 3 years, beginning with potential best-in-class Tissue Factor